Device Trial Radar · NCT06047964
SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis
Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
281
Actual
Start
Mar 23, 2023
Primary completion
Sep 29, 2024
Study completion Sep 30, 2026
Sponsor
- Lead sponsor
- B. Braun Medical International Trading Company Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 21, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is aiming to evaluate the safety and efficacy of SeQuent® Please CIS in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis and restenosis after interventional therapy.
Conditions
- Stroke
- Intracranial Atherosclerotic Stenosis
Interventions
DCBDevice
Intracranial paclitaxel drug-eluting balloon catheters (SeQuent® Please CIS)
POBADevice
Intracranial PTA balloon catheter
Primary outcomes
What the sponsor says the trial is designed to measure.
- restenosis incidence of target lesionTime frame: 6 months post-procedure
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.